Ownership history in Caption Management, LLC · 8 quarters on record
This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in UROGEN PHARMA LTD (URGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 1,000,000 | — | 0% | 0.16% | $23.4M | $23.42 |
| 2025 Q3 | ADDED | 1,000,000 | +930,000 | +1328.6% | 0.16% | $19.9M | $19.95 |
| 2025 Q3 | ADDED | 70,000 | +20,000 | +40.0% | 0.01% | $1.4M | $19.95 |
| 2025 Q2 | REDUCED | 50,000 | -18,000 | -26.5% | 0.01% | $685K | $13.70 |
| 2024 Q2 | REDUCED | 68,000 | -5,700 | -7.7% | 0.02% | $1.1M | $16.78 |
| 2024 Q2 | ADDED | 73,700 | +71,300 | +2970.8% | 0.02% | $1.2M | $16.78 |
| 2023 Q2 | UNCHANGED | 2,400 | — | 0% | 0.00% | $25K | $10.35 |
| 2023 Q2 | INITIATED | 2,400 | — | — | 0.00% | $25K | $10.35 |
As of 2025 Q4 — sorted by position size